Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|February 13, 1993
Influence of coexisting disease on survival on renal-replacement therapyI H Khan, G R Catto, N Edward, et al.
International Archives of Allergy and Applied Immunology|January 1, 1984
Non-cytotoxic alloantibodies defined by the EA rosette inhibition assayR J Mason, A M Macleod, D A Power, et al.
Diagnostic Imaging|January 1, 1982
Nuclear magnetic resonance tomographic imaging in renal diseaseF W Smith, A Reid, J R Mallard, et al.
Journal of Clinical Pathology|July 1, 1987
Non-cytotoxic antibodies in chronic lymphocytic leukaemiaA M MacLeod, E J Minford, D J King, et al.
The Quarterly Journal of Medicine|January 1, 1982
Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophyN Muirhead, S Adami, L M Sandler, et al.
Scottish Medical Journal|January 1, 1985
Acute renal failure: the tip of the iceberg?D A Power, J Haughney, A J Nicholls, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophyN Muirhead, G R Catto, N Edward, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Pretransplant antibodies and renal allograft survivalA M MacLeod, R J Mason, D A Power, et al.
Pageof 12